Surmodics
Bookmark
ShareCopied to clipboardSurmodics is a company. It is a public company in Eden Prairie, the United States. It was founded in 1979 and its current CEO is Gary R. Maharaj. It is part of the Health Care sector, specifically in the Health Care Equipment & Supplies industry.
Key facts
- city: Eden Prairie
- country: United States
- employees: 389 people
- revenues: 125.4M $
- company type: public
- sector: Health Care
- industry: Health Care Equipment & Supplies
- foundation year: 1979
- CEO: Gary R. Maharaj
- CEO approval: 77 %
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about Surmodics:
Dataset of stocks from Surmodics:
Surmodics is one of the companies in the United States, companies in Health Care Equipment & Supplies, companies in Health Care, companies in Eden Prairie and 3,456,808 companies in our database.
Talking Points
- Surmodics: Medical Device Coatings & In Vitro Diagnostics (IVD)
- Surmodics, Inc. is a leading provider of surface modification, drug delivery, and in vitro diagnostic technologies to the healthcare industry.
- To improve the detection and treatment of disease. | Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated medical devices that are designed to ...
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.